Add BrightSurf on Google Email

Cardiovascular events 1 year after RSV infection in adults

A cohort study of adults aged 45 or older with RSV infection found a significant excess risk of cardiovascular events over 1 year, comparable in magnitude to influenza infection. This highlights the importance of RSV as a potential risk factor for cardiovascular morbidity and underscores the need for vaccination to mitigate this burden.

SourceJAMA Network·JournalJAMA Network Open·DateDec 8, 2025

Americans more likely to accept guidance from AMA than CDC on vaccine safety

A survey of adults in the US found that most people prefer the American Medical Association's (AMA) guidance on vaccine safety over the Centers for Disease Control and Prevention's (CDC), citing concerns about the CDC's recent changes to its website. According to the survey, 35% of Americans would accept the AMA's recommendation, while...

Beat the bugs, enjoy the beats

A comprehensive review of 19 multi-day events found that nearly 70% of reported emergencies were infectious disease outbreaks, with influenza, measles, and meningococcal disease being the top causes. Foodborne illnesses accounted for over one in five incidents, often linked to poor food handling practices.

SourceFlinders University·JournalPublic Health·TypeSystematic review·DateDec 1, 2025

Children’s Hospital of Philadelphia researchers show how circadian rhythms help boost infection recovery

Researchers at Children's Hospital of Philadelphia found that circadian rhythms play a crucial role in boosting infection recovery in critically ill patients with respiratory viral infections. Maintaining a rhythmic meal schedule can mitigate the effects of disrupted light cycles and improve outcomes.

SourceChildren's Hospital of Philadelphia·JournalJournal of Clinical Investigation·TypeExperimental study·DateDec 1, 2025

Fighting two infections at once

A study found that hepatitis C treatment with direct-acting antivirals (DAAs) improves immune function in individuals co-infected with HIV and HCV, even in those with advanced liver disease. The treatment resulted in significant declines in inflammation and liver damage markers.

SourceKyoto University·JournalJournal of Medical Virology·TypeRandomized controlled/clinical trial·DateNov 26, 2025

Hospital infections associated with higher risk of dementia

A new meta-analysis published in Aging-US found a significant association between hospitalization for infections and the risk of developing dementia. Adults hospitalized with infections were at an increased risk of all-cause dementia, especially after a single infection-related hospitalization, which can speed up cognitive decline.

SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateNov 25, 2025

‘Mental model’ approach shows promise in reducing susceptibility to misconceptions about mRNA vaccination

Researchers tested a 'mental model' approach to counter unwarranted fears about mRNA technology. The study found that exposing people to visual models of how vaccines work and/or how cells protect DNA from foreign fragments undercuts the effect of exposure to misconceptions.

SourceAnnenberg Public Policy Center of the University of Pennsylvania·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateNov 24, 2025

New research confirms HPV vaccination prevents cervical cancer

Two new Cochrane reviews show that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus. Girls vaccinated before the age of 16 were found to be 80% less likely to develop cervical cancer.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateNov 23, 2025

The road ahead: Why conserving the invisible 99% of life is fundamental to planetary health

A new paper outlines a global coalition dedicated to conserving microbial biodiversity, which accounts for 99% of life on Earth. The Microbial Conservation Specialist Group will develop Red List-compatible metrics, pilot restoration projects, and promote public awareness to ensure microbes are recognized as essential to planetary health.

SourceApplied Microbiology International·JournalSustainable Microbiology·DateNov 20, 2025

New nanogel technology destroys drug-resistant bacteria in hours

A novel nanogel technology has been developed to kill drug-resistant bacteria, including Pseudomonas aeruginosa and Escherichia coli, with high selectivity and efficiency. The technology uses a heteromultivalent nanogel that binds to specific proteins on the bacterial surface, disrupting the membrane and leading to rapid bacterial death.

SourceSwansea University·JournalAngewandte Chemie·TypeExperimental study·DateNov 19, 2025

Global and European experts convene in Warsaw for Europe’s leading public health conference on infectious diseases

The 2025 European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) brings together over 3,000 participants to exchange knowledge and strengthen collaboration in infectious disease prevention and control. The conference highlights urgent priorities such as building trust in science, demonstrating science-based ...

Scientists use computer model to improve hospitals’ ability to limit spread of drug-resistant infections

A new analytical tool can improve a hospital's ability to limit the spread of antibiotic-resistant infections by inferring asymptomatic carriers. The method, developed by Columbia University researchers, combines multiple data sources to predict the spread of an infection in the hospital setting.

SourceColumbia University's Mailman School of Public Health·JournalNature Communications·TypeExperimental study·DateNov 19, 2025

Apriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines

The partnership aims to co-develop and evaluate next-generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza. Apriori's Octavia platform will be combined with A*STAR IDL's saRNA delivery technology to develop improved H5 influenza vaccines that anticipate infection in humans.

Study in Europe: monoclonal antibodies effectively prevent respiratory syncytial virus in infants

A European study found that long-acting monoclonal antibody immunisation effectively prevented hospitalisation due to RSV infection among children under two years old. The overall immunisation effectiveness was 79%, with a decline in protection over time, highlighting the need for ongoing monitoring.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateNov 13, 2025

MIT research finds particles that enhance mRNA delivery could reduce vaccine dosage and costs

Researchers have developed particles that can deliver an effective immune response at a much lower dose than traditional mRNA vaccines. The new particles, called AMG1541, use cyclic structures and ester groups to enhance mRNA delivery and improve biodegradability. This could potentially reduce vaccine costs and side effects.

SourceMassachusetts Institute of Technology·JournalNature Nanotechnology·DateNov 7, 2025

New study shows invasive Group A Streptococcus outcomes shaped by treatment strategies, not species lineage

Researchers found that early clindamycin administration significantly improved recovery rates in patients with invasive Group A Streptococcus (iGAS) infections. The study also showed that M1uk strain does not worsen prognosis in critically ill adults, but prompt treatment remains crucial.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeObservational study·DateNov 6, 2025

New study reveals not all bats carry equal viral risk

A new study identifies specific bat species carrying viruses with high epidemic potential. The research highlights that not all bats carry the same level of viral risk, and conservation efforts can help mitigate this risk by protecting habitats. Understanding which bat groups harbor deadly viruses can aid in developing therapeutics.

SourceUniversity of Oklahoma·JournalCommunications Biology·DateNov 3, 2025

Biomaterial vaccines to make implanted orthopedic devices safer

Researchers have developed a novel vaccine strategy using biomaterial scaffold vaccines to protect against Staphylococcus aureus infections in orthopedic device implants. The vaccines, made with immune cell-attaching molecules and S. aureus-specific antigens, create a beneficial immune response that significantly lowers bacterial burden.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateNov 3, 2025

New editorial urges clinicians to address sex-based disparities in sepsis treatment

The editorial highlights how biological sex and gender inequities contribute to suboptimal sepsis treatment, potentially compromising outcomes for women. Hormonal fluctuations, body composition, and renal clearance all influence drug processing, yet these variables are rarely considered in dosing algorithms.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeCommentary/editorial·DateOct 31, 2025

USF study: AI and citizen science reveal potential first detection of invasive malaria mosquito in Madagascar

Researchers from the University of South Florida have used artificial intelligence and citizen science to identify what may be the first specimen of Anopheles stephensi — an invasive and deadly malaria-carrying mosquito — ever detected in Madagascar. The study demonstrates how AI-powered image recognition and public participation can t...

SourceUniversity of South Florida·JournalInsects·TypeCase study·DateOct 28, 2025

A new tool for healthcare gives better outbreak forecasts

A new approach, epimodulation, has been developed to improve epidemiological forecasting models by incorporating critical pieces of understanding into the models. This approach increased model accuracy by up to 55% during epidemic peaks for hospital admission forecasts without reducing accuracy at non-peak times.

SourceUniversity of Texas at Austin·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateOct 24, 2025

Common source, common food vehicle: investigations of recurring Salmonella Strathcona outbreaks in Europe since 2011

A recurring seasonal outbreak pattern of Salmonella Strathcona cases has been identified in Europe since 2011, with small tomatoes from Sicily being the likely source. The investigation found that almost all cases were genetically related, suggesting a common source and food vehicle.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateOct 21, 2025

Mosquito saliva may hold clues to fighting chikungunya inflammation

A*STAR researchers discovered that mosquito saliva not only transmits the virus but also influences how the body's immune system responds to chikungunya infection. Sialokinin, a bioactive peptide in Aedes mosquito saliva, binds to neurokinin receptors on immune cells and suppresses monocyte activation.

SourceAgency for Science, Technology and Research (A*STAR), Singapore·JournalNature Communications·TypeExperimental study·DateOct 20, 2025

Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies

A new human lung alveolus chip model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy. The study achieved significant reductions in virus load and host inflammatory response after a single administration.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalLab on a Chip·TypeExperimental study·DateOct 15, 2025